𝔖 Bobbio Scriptorium

✦ LIBER ✦

The search for a PCP antagonist: Synthesis and characterization of novel arylcyclohexylamine derivatives: Reel, J. K., L. G. Mendelsohn, J. D. Leander, D. M. Zimmerman, P. L. Ornstein, D. A. Evrard, D. D. Schoepp and R. B. Hermann. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

Book ID: 113221081
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 111 KB
Volume: 28
Category: Article
ISSN: 0091-3057
DOI: 10.1016/0091-3057(87)90079-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The search for a phencyclidine (PCP) ant

The search for a phencyclidine (PCP) antagonist. PCP-like effects of a series of substituted dioxolanes related to dexoxadrol: Ornstein, P. L., D. M. Zimmerman, D. J. Leander, L. Mendelsohn, J. K. Reel and D. A. Evrard. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 123 KB

The search for a PCP antagonist. The dis

The search for a PCP antagonist. The discovery of potent PCP-like activity in a hexahydroindeno [2,1-c] pyridine series of compounds: Cantrell, B. E., L. G. Mendelsohn, D. D. Schoepp, J. D. Leander, R. B. Hermann and D. M. Zimmerman. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 105 KB

43 The discovery and general SAR studies

43 The discovery and general SAR studies of a novel class of potent non-nucleoside reverse transcriptase inhibitors: R. J. Ternansky1, J. M. Morin, Jr.1, C. Lopez1, C. J. Paget, Jr.1, F. W. Bell1, A. S. Cantrell1, S. R. Jaskunas1, C. L. Jordan1, M. D. Kinnick1, J. A. Palkowitz1, C. A. Parrish1, P. Pranc1, R. T. Vasileff1, S. J. West1, M. Hogberg2, P. Lind2, R. Noreen2, C. Sahlberg2, X.-X. Zhou2, L. Vrang2, C. Rydergard2, C. Ahgren2, B. Oberg2, and N. G. Johansson2. 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Medivir AB, Huddinge, Sweden

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 50 KB

60 Inhibition of wild type and mutant HI

60 Inhibition of wild type and mutant HIV reverse transcriptases by a new class of non-nucleoside reverse transcriptase inhibitors: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg2, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, A. S. Cantrell3, S. R. Jaskunas3, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1. 1Medivir AB, Huddinge, Sweden; 2Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 57 KB

44 Combination of LY300082 with AZT and

44 Combination of LY300082 with AZT and DDI give synergistic effects on HIV replication in cells and on HIV reverse transcriptase: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg1, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1,2. 1Medivir AB, Huddinge, Sweden; Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 50 KB